|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07H 19/173 | (2006.01) |
| A61K 31/7076 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3224268 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15804216.8 |
| Date of filing the European patent application | 2015-11-27 | |
| (97) | Date of publication of the European application | 2017-10-04 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-26 |
| (46) | Date of publication of the claims translation | 2019-09-25 |
| (86) | Number | PCT/GB2015/053628 |
| Date | 2015-11-27 |
| (87) | Number | WO 2016/083830 |
| Date | 2016-06-02 |
| (30) | Number | Date | Country code |
| 201421211 | 2014-11-28 | GB | |
| 201519316 | 2015-11-02 | GB |
| (72) |
GRIFFITH, Hugh, GB
MCGUIGAN, Christopher, GB
FERRARI, Valentina, GB
SERPI, Michaela, GB
JIMENEZ ANTUNEZ, Carmen, GB
|
| (73) |
NuCana plc,
77-78 Cannon Street, London EC4N 6AF,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Naujieji 2` ir (arba) 5` aminorūgšties esterio fosforamidato 3`-deoksi adenozino dariniai, kaip priešvėžiniai junginiai |
| NEW 2` AND/OR 5` AMINO-ACID ESTER PHOSPHORAMIDATE 3`-DEOXY ADENOSINE DERIVATIVES AS ANTI-CANCER COMPOUNDS |
| Payment date | Validity (years) | Amount | |
| 2025-10-28 | 11 | 289.00 EUR |
| 2026-11-27 |